# Ep. 181: Advancements in CIDP Treatment

Page: https://stenobird.com/podcast/eancast-weekly-neurology-5497158/ep-181-advancements-in-cidp-treatment
Text version: https://stenobird.com/podcast/eancast-weekly-neurology-5497158/ep-181-advancements-in-cidp-treatment.md
Podcast: [eanCast: Weekly Neurology](https://stenobird.com/podcast/eancast-weekly-neurology-5497158)
Published: 2025-12-28T23:15:00+00:00
Episode link: https://eancast.podigee.io/181-ep-181-advancements-in-cidp-treatment
Audio file: https://audio.podigee-cdn.net/2275474-m-db72fefecf88301d8aaf2a72f23c87a1.mp3?source=feed
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-181-advancements-in-cidp-treatment
Duration seconds: 1975

## Resource

Moderator: Rob Hadden (London, United Kingdom) Guest: Claudia Sommer (Würzburg, Germany) In this episode, Rob Hadden and Claudia Sommer discuss ongoing challenges in treating CIDP. While most patients benefit from current therapies, some remain treatment-refractory, driving the need for innovation. They highlight emerging response definitions, promising FcRn and complement inhibitors, and the importance of individualized care and serum biomarkers for improving patient outcomes. This episode has been supported by an educational grant from argenx. The programme has not been influenced in any way by its supporter.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-181-advancements-in-cidp-treatment/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/eancast-weekly-neurology-5497158/ep-181-advancements-in-cidp-treatment.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.